Alnylam Pharmaceuticals (ALNY) Exchange Rate Effect (2009 - 2026)

Alnylam Pharmaceuticals' Exchange Rate Effect history runs 9 years deep, the most recent figure standing at -$7.1 million for Q1 2026.

• Quarterly Exchange Rate Effect fell 150.25% year-over-year to -$7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.8 million (up 57.69% YoY) and the FY2025 annual result came in at $34.9 million, up 329.25% from the prior year.
• Exchange Rate Effect was -$7.1 million for Q1 2026 at Alnylam Pharmaceuticals, down from -$5.7 million in the prior quarter.
• Across five years, Exchange Rate Effect topped out at $27.5 million in Q2 2025 and bottomed at -$17.3 million in Q4 2024.
• A 5-year average of $682000.0 and a median of -$927000.0 in 2025 frame the typical range for Exchange Rate Effect.
• Annual changes were most pronounced in 2024 — Exchange Rate Effect slumped 2300.0% — and 2025, when it soared 981.6%.
• Alnylam Pharmaceuticals' Exchange Rate Effect stood at $1.6 million in 2022, then jumped by 573.07% to $10.9 million in 2023, then plunged by 258.49% to -$17.3 million in 2024, then soared by 66.99% to -$5.7 million in 2025, then declined by 23.91% to -$7.1 million in 2026.
• Business Quant data shows ALNY's Exchange Rate Effect at -$7.1 million in Q1 2026, -$5.7 million in Q4 2025, and -$927000.0 in Q3 2025.